{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:41:34Z","timestamp":1793295694227,"version":"4.5.0"},"reference-count":158,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is the most prevalent cause of dementia worldwide, disproportionately affecting women and lacking effective disease-modifying therapies. While traditional approaches have focused on amyloid \u03b2 (A\u03b2) plaques and tau pathology, emerging evidence highlights the role of metabolic dysfunction, mitochondrial impairment, and hormonal signaling in the pathogenesis of AD. Estrogens exert neuroprotective effects by modulating synaptic plasticity, enhancing mitochondrial bioenergetics, and reducing oxidative stress and inflammation. Similarly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for the treatment of type 2 diabetes, have demonstrated promising cognitive benefits, potentially mediated through improved insulin signaling, neuronal survival, and reduced \u03b2-amyloid (A\u03b2) and tau burden. This review explores the converging mechanisms through which estrogens and GLP-1RAs may act synergistically to prevent or delay the onset of AD. We examine the influence of sex differences in mitochondrial dynamics, estrogen receptor distribution, and GLP-1 signaling pathways, particularly within central nervous system regions implicated in AD. Preclinical studies using GLP-1-estrogen conjugates have shown enhanced metabolic and neuroprotective outcomes, accompanied by reduced systemic hormonal exposure, suggesting a viable therapeutic strategy. As the global prevalence of AD continues to rise, especially among postmenopausal women, dual agonism targeting estrogen and GLP-1 receptors may represent a novel, physiologically informed approach to prevention and intervention. Ongoing clinical trials and future research must consider sex-specific factors, receptor polymorphisms, and brain-region selectivity to optimize the translational potential of this combined strategy.<\/jats:p>","DOI":"10.3389\/fmolb.2025.1622186","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:10:49Z","timestamp":1750911049000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Hormonal modulation, mitochondria and Alzheimer\u2019s prevention: the role of GLP-1 agonists and estrogens"],"prefix":"10.3389","volume":"12","author":[{"given":"Fernando","family":"Lizcano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Sanabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Aviles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/nu15051107","article-title":"Polyphenols mediate neuroprotection in cerebral ischemic stroke-an update","volume":"15","author":"Abdelsalam","year":"2023","journal-title":"Nutrients"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.2337\/db17-1385","article-title":"Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing glutamatergic neurons","volume":"67","author":"Adams","year":"2018","journal-title":"Diabetes"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1533317519899546","DOI":"10.1177\/1533317519899546","article-title":"Antidiabetic drugs for the risk of alzheimer disease in patients with type 2 DM using FAERS","volume":"35","author":"Akimoto","year":"2020","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"key":"B4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.mito.2008.02.001","article-title":"Nuclear receptors, mitochondria and lipid metabolism","volume":"8","author":"Alaynick","year":"2008","journal-title":"Mitochondrion"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1152\/physrev.2001.81.3.1269","article-title":"Nuclear hormone receptors and gene expression","volume":"81","author":"Aranda","year":"2001","journal-title":"Physiol. Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/bcpt.14035","article-title":"Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: a focused review","volume":"135","author":"Arjmand","year":"2024","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"a039057","DOI":"10.1101\/cshperspect.a039057","article-title":"Integrating sex chromosome and endocrine theories to improve teaching of sexual differentiation","volume":"14","author":"Arnold","year":"2022","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"108824","DOI":"10.1016\/j.pharmthera.2025.108824","article-title":"GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders?","volume":"269","author":"Arredouani","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/neu.1038","article-title":"Brain aromatase is neuroprotective","volume":"47","author":"Azcoitia","year":"2001","journal-title":"J. Neurobiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: the core pathogenesis and mechanism of Alzheimer's disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/1533317515602548","article-title":"Mammillary bodies in Alzheimer's disease: a golgi and electron microscope study","volume":"31","author":"Baloyannis","year":"2016","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"key":"B14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/1533317514556876","article-title":"The hypothalamus in Alzheimer's disease: a Golgi and electron microscope study","volume":"30","author":"Baloyannis","year":"2015","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.02.005","article-title":"Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?","volume":"118","author":"Bassil","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.gheart.2016.10.024","article-title":"The global burden of disease study and the preventable burden of NCD","volume":"11","author":"Benziger","year":"2016","journal-title":"Glob. Heart"},{"key":"B17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5334\/gh.1130","article-title":"Urbanization, altitude and cardiovascular risk","volume":"17","author":"Bernabe-Ortiz","year":"2022","journal-title":"Glob. Heart"},{"key":"B18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1152\/physiol.00054.2015","article-title":"Aromatase: contributions to physiology and disease in women and men","volume":"31","author":"Blakemore","year":"2016","journal-title":"Physiol. (Bethesda)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"bqae165","DOI":"10.1210\/endocr\/bqae165","article-title":"GLP-1 and its analogs: does sex matter?","volume":"166","author":"Borchers","year":"2025","journal-title":"Endocrinology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3390\/biology11121698","article-title":"Brain-derived estrogen and neurological disorders","volume":"11","author":"Brann","year":"2022","journal-title":"Biol. (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/JAD-190835","article-title":"Age-related intraneuronal aggregation of amyloid-beta in endosomes, mitochondria, autophagosomes, and lysosomes","volume":"73","author":"Brewer","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"574111","DOI":"10.3389\/fpubh.2020.574111","article-title":"Management and prevention strategies for non-communicable diseases (NCDs) and their risk factors","volume":"8","author":"Budreviciute","year":"2020","journal-title":"Front. Public Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1210\/endo.137.7.8770921","article-title":"Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor","volume":"137","author":"Bullock","year":"1996","journal-title":"Endocrinology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2337\/diabetes.52.1.124","article-title":"Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor","volume":"52","author":"Buteau","year":"2003","journal-title":"Diabetes"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.3390\/ijms19092505","article-title":"GLP-1 analogue liraglutide attenuates mutant huntingtin-induced neurotoxicity by restoration of neuronal insulin signaling","volume":"19","author":"Chang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2011.12.063","article-title":"Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation","volume":"1441","author":"Correia","year":"2012","journal-title":"Brain Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S357","DOI":"10.3233\/JAD-240730","article-title":"Incretin mimetics as potential disease modifying treatment for Alzheimer's disease","volume":"101","author":"Crook","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","article-title":"Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial","volume":"19","author":"Cukierman-Yaffe","year":"2020","journal-title":"Lancet Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13195-024-01666-7","article-title":"Evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease","volume":"17","author":"Cummings","year":"2025","journal-title":"Alzheimers Res. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1172\/JCI91761","article-title":"Age-dependent human beta cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling","volume":"127","author":"Dai","year":"2017","journal-title":"J. Clin. Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"eaaz5677","DOI":"10.1126\/scitranslmed.aaz5677","article-title":"A second X chromosome contributes to resilience in a mouse model of Alzheimer's disease","volume":"12","author":"Davis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"10263","DOI":"10.1074\/jbc.M115.695825","article-title":"Loss of mitochondrial function impairs lysosomes","volume":"291","author":"Demers-Lamarche","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00125-023-05906-7","article-title":"The expanding incretin universe: from basic biology to clinical translation","volume":"66","author":"Drucker","year":"2023","journal-title":"Diabetologia"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1073\/pnas.84.10.3434","article-title":"Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line","volume":"84","author":"Drucker","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1033479","DOI":"10.3389\/fendo.2022.1033479","article-title":"The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer's disease","volume":"13","author":"Du","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00439-005-0123-8","article-title":"Does the mitochondrial genome play a role in the etiology of Alzheimer's disease?","volume":"119","author":"Elson","year":"2006","journal-title":"Hum. Genet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13063-019-3259-x","article-title":"Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)","volume":"20","author":"Femminella","year":"2019","journal-title":"Trials"},{"key":"B41","doi-asserted-by":"publisher","first-page":"45076","DOI":"10.1038\/srep45076","article-title":"Acute and chronic mitochondrial respiratory chain deficiency differentially regulate lysosomal biogenesis","volume":"7","author":"Fernandez-Mosquera","year":"2017","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/nm.3009","article-title":"Targeted estrogen delivery reverses the metabolic syndrome","volume":"18","author":"Finan","year":"2012","journal-title":"Nat. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/brain\/awad024","article-title":"Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study","volume":"146","author":"Florian","year":"2023","journal-title":"Brain"},{"key":"B44","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1101\/lm.037267.114","article-title":"Sex steroid hormones matter for learning and memory: estrogenic regulation of hippocampal function in male and female rodents","volume":"22","author":"Frick","year":"2015","journal-title":"Learn Mem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fnagi.2016.00108","article-title":"In Alzheimer's disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial","volume":"8","author":"Gejl","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1124\/pr.109.002071","article-title":"Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines","volume":"62","author":"Gillies","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1194\/jlr.R076331","article-title":"Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention","volume":"58","author":"Grimm","year":"2017","journal-title":"J. Lipid Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cell.2024.10.027","article-title":"Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes","volume":"188","author":"Guo","year":"2025","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/CIRCRESAHA.108.190892","article-title":"Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity","volume":"104","author":"Haas","year":"2009","journal-title":"Circ. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/1567205052772786","article-title":"Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease","volume":"2","author":"Han","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1001\/jama.2024.10333","article-title":"Poll: roughly 12% of US adults have used a GLP-1 drug, even if unaffordable","volume":"332","author":"Harris","year":"2024","journal-title":"JAMA"},{"key":"B52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.plipres.2010.09.001","article-title":"Apolipoprotein E: from lipid transport to neurobiology","volume":"50","author":"Hauser","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s43440-022-00405-9","article-title":"Contribution of hyperglycemia-induced changes in microglia to Alzheimer's disease pathology","volume":"74","author":"Hernandez-Rodriguez","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1210\/jc.2003-030862","article-title":"Changes in estrogen receptor-alpha and -beta in the infundibular nucleus of the human hypothalamus are related to the occurrence of Alzheimer's disease neuropathology","volume":"89","author":"Hestiantoro","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1210\/en.2017-00349","article-title":"Role of ER\u03b1 in mediating female uterine transcriptional responses to IGF1","volume":"158","author":"Hewitt","year":"2017","journal-title":"Endocrinology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuropharm.2018.01.040","article-title":"Novel dual GLP-1\/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models","volume":"136","author":"Holscher","year":"2018","journal-title":"Neuropharmacology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/(sici)1096-8628(19980207)81:1<117::aid-ajmg19>3.0.co;2-m","article-title":"ApoE genotype is a risk factor in nonpresenilin early-onset alzheimer's disease families","volume":"81","author":"Houlden","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases","author":"Huang","year":"2014","journal-title":"Neurobiol. Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2826.2011.02251.x","article-title":"Selective oestrogen receptor modulators differentially potentiate brain mitochondrial function","volume":"24","author":"Irwin","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-024-00988-2","article-title":"Multifaceted roles of APOE in Alzheimer disease","volume":"20","author":"Jackson","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00702-024-02792-0","article-title":"Depression and anxiety in multiple sclerosis. Review of a fatal combination","volume":"131","author":"Jellinger","year":"2024","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3389\/fphar.2018.01168","article-title":"GLP-1 improves adipocyte insulin sensitivity following induction of endoplasmic reticulum stress","volume":"9","author":"Jiang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1362519","DOI":"10.3389\/fendo.2024.1362519","article-title":"Editorial: endocrine disruptors and diseases of brain and mind: past and prelude","volume":"15","author":"Johri","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.18632\/oncotarget.23640","article-title":"Drp1\/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease","volume":"9","author":"Joshi","year":"2018","journal-title":"Oncotarget"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/jamaneurol.2019.2462","article-title":"Association of extracellular vesicle biomarkers with alzheimer disease in the Baltimore longitudinal study of aging","volume":"76","author":"Kapogiannis","year":"2019","journal-title":"JAMA Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.1073\/pnas.1721732115","article-title":"Increase in chemokine CXCL1 by ER\u03b2 ligand treatment is a key mediator in promoting axon myelination","volume":"115","author":"Karim","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B69","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.ijo.0802206","article-title":"Entry of exendin-4 into brain is rapid but may be limited at high doses","volume":"27","author":"Kastin","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"B70","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.yfrne.2012.07.002","article-title":"Membrane-initiated actions of estradiol that regulate reproduction, energy balance and body temperature","volume":"33","author":"Kelly","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12488","article-title":"Structural and functional characteristics of oestrogen receptor beta splice variants: implications for the ageing brain","volume":"30","author":"Kim","year":"2018","journal-title":"J. Neuroendocrinol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement. (N Y)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.jmb.2017.04.004","article-title":"TREM2-Ligand interactions in Health and disease","volume":"429","author":"Kober","year":"2017","journal-title":"J. Mol. Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/s0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7-36: a physiological incretin in man","volume":"2","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"B77","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/cne.10899","article-title":"Estrogen-receptor-beta distribution in the human hypothalamus: similarities and differences with ER alpha distribution","volume":"466","author":"Kruijver","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/(sici)1097-4695(19980905)36:3<357::aid-neu5>3.0.co;2-v","article-title":"Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype","volume":"36","author":"Laflamme","year":"1998","journal-title":"J. Neurobiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"S379","DOI":"10.3233\/JAD-179944","article-title":"Iron and Alzheimer's disease: an update on emerging mechanisms","volume":"64","author":"Lane","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10522-013-9431-x","article-title":"Effect of estrogens on base excision repair in brain and liver mitochondria of aged female rats","volume":"14","author":"Leclere","year":"2013","journal-title":"Biogerontology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3233\/ADR-230181","article-title":"Clinical evidence for GLP-1 receptor agonists in Alzheimer's disease: a systematic review","volume":"8","author":"Liang","year":"2024","journal-title":"J. Alzheimers Dis. Rep."},{"key":"B83","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"B84","doi-asserted-by":"publisher","first-page":"921504","DOI":"10.3389\/fendo.2022.921504","article-title":"Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes","volume":"13","author":"Lizcano","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"757461","DOI":"10.1155\/2014\/757461","article-title":"Estrogen deficiency and the origin of obesity during menopause","volume":"2014","author":"Lizcano","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B86","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cell.2006.04.021","article-title":"The expanding cosmos of nuclear receptor coactivators","volume":"125","author":"Lonard","year":"2006","journal-title":"Cell"},{"key":"B87","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3233\/JAD-2012-120283","article-title":"New evidence of mitochondria dysfunction in the female Alzheimer's disease brain: deficiency of estrogen receptor-\u03b2","volume":"30","author":"Long","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.neuron.2024.01.024","article-title":"Mechanisms of sex differences in Alzheimer's disease","volume":"112","author":"Lopez-Lee","year":"2024","journal-title":"Neuron"},{"key":"B90","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fendo.2020.00148","article-title":"Does GPER really function as a G protein-coupled estrogen receptor in vivo?","volume":"11","author":"Luo","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","article-title":"Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage","volume":"20","author":"Manczak","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B92","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2174\/138920206779315737","article-title":"Estrogen signaling multiple pathways to impact gene transcription","volume":"7","author":"Marino","year":"2006","journal-title":"Curr. Genomics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/mi.3.5.281","article-title":"Estrogen signaling: a subtle balance between ER alpha and ER beta","volume":"3","author":"Matthews","year":"2003","journal-title":"Mol. Interv."},{"key":"B94","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/er.2012-1055","article-title":"The role of estrogens in control of energy balance and glucose homeostasis","volume":"34","author":"Mauvais-Jarvis","year":"2013","journal-title":"Endocr. Rev."},{"key":"B95","doi-asserted-by":"publisher","first-page":"8701","DOI":"10.1523\/JNEUROSCI.23-25-08701.2003","article-title":"Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection","volume":"23","author":"McCullough","year":"2003","journal-title":"J. Neurosci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/9780470514757.ch4","article-title":"Oestrogens and the structural and functional plasticity of neurons: implications for memory, ageing and neurodegenerative processes","volume":"191","author":"McEwen","year":"1995","journal-title":"Ciba Found. Symp."},{"key":"B97","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0531-5565(94)90022-1","article-title":"Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain","volume":"29","author":"McEwen","year":"1994","journal-title":"Exp. Gerontol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e00525","DOI":"10.1016\/j.neurot.2025.e00525","article-title":"Mitochondrial dysfunction in Alzheimer's disease: guiding the path to targeted therapies","volume":"22","author":"McGill Percy","year":"2025","journal-title":"Neurotherapeutics"},{"key":"B99","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2174\/1871522211108040255","article-title":"GPER\/GPR30 and regulation of vascular tone and blood pressure","volume":"11","author":"Meyer","year":"2011","journal-title":"Immunol. Endocr. Metab. Agents Med. Chem."},{"key":"B100","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1152\/advan.00039.2012","article-title":"In pursuit of scientific excellence: sex matters","volume":"36","author":"Miller","year":"2012","journal-title":"Adv. Physiol. Educ."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1210\/en.2002-221069","article-title":"Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha","volume":"144","author":"Mitra","year":"2003","journal-title":"Endocrinology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.dsx.2016.01.021","article-title":"Shared links between type 2 diabetes mellitus and Alzheimer's disease: a review","volume":"10","author":"Mittal","year":"2016","journal-title":"Diabetes Metab. Syndr."},{"key":"B103","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1172\/JCI112855","article-title":"Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas","volume":"79","author":"Mojsov","year":"1987","journal-title":"J. Clin. Invest"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e1391","DOI":"10.1212\/WNL.0000000000207663","article-title":"Randomized phase II study of the safety and efficacy of semorinemab in participants with mild-to-moderate alzheimer disease: lauriet","volume":"101","author":"Monteiro","year":"2023","journal-title":"Neurology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13195-020-00646-x","article-title":"One third of dementia cases can be prevented within the next 25 years by tackling risk factors. The case \u201cfor\u201d and \u201cagainst\u201d","volume":"12","author":"Montero-Odasso","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.bbagen.2009.11.002","article-title":"Modulation of synaptic plasticity by brain estrogen in the hippocampus","volume":"1800","author":"Mukai","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1210\/ME.2015-1124","article-title":"17\u03b2-Estradiol ameliorates tight junction disruption via repression of MMP transcription","volume":"29","author":"Na","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"101815","DOI":"10.1016\/j.arr.2022.101815","article-title":"Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer's disease","volume":"85","author":"Neha","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"B109","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","article-title":"Insulin resistance and Alzheimer's disease: bioenergetic linkages","volume":"9","author":"Neth","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","article-title":"Apolipoprotein E genotype and sex risk factors for alzheimer disease: a meta-analysis","volume":"74","author":"Neu","year":"2017","journal-title":"JAMA Neurol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"14069","DOI":"10.1523\/JNEUROSCI.4391-07.2007","article-title":"Estradiol in vivo regulation of brain mitochondrial proteome","volume":"27","author":"Nilsen","year":"2007","journal-title":"J. Neurosci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/j.1476-5381.2011.01235.x","article-title":"G protein-coupled oestrogen receptor 1 (GPER1)\/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling","volume":"163","author":"Nilsson","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"e12268","DOI":"10.1002\/trc2.12268","article-title":"Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers","volume":"8","author":"Norgaard","year":"2022","journal-title":"Alzheimers Dement. (N Y)"},{"key":"B114","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"B115","volume-title":"Global status report on the public health response to dementia: executive summary","author":"D.o.M.H.a.S.U.W.H.","year":"2021"},{"key":"B116","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2174\/1567205012666150710112618","article-title":"Mitochondrial deficits accompany cognitive decline following single bilateral intracerebroventricular streptozotocin","volume":"12","author":"Paidi","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/antiox13020240","article-title":"Mitochondria dysfunction and neuroinflammation in neurodegeneration: who comes first?","volume":"13","author":"Peggion","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.2174\/1567205015666180911151716","article-title":"The role of lipids and membranes in the pathogenesis of Alzheimer's disease: a comprehensive view","volume":"15","author":"Penke","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.eprac.2024.01.006","article-title":"Endocrine disruptors and metabolic changes: impact on puberty control","volume":"30","author":"Peralta","year":"2024","journal-title":"Endocr. Pract."},{"key":"B120","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1124\/jpet.107.134072","article-title":"Mitochondrial effects of estrogen are mediated by estrogen receptor alpha in brain endothelial cells","volume":"325","author":"Razmara","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B121","doi-asserted-by":"publisher","first-page":"970925","DOI":"10.3389\/fnins.2022.970925","article-title":"The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: an in-depth review","volume":"16","author":"Reich","year":"2022","journal-title":"Front. Neurosci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study","volume":"11","author":"Reiman","year":"2020","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer\u2019s disease facts and figures","volume":"20","author":"Report","year":"2024","journal-title":"Alzheimers Dement"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e0119034","DOI":"10.1371\/journal.pone.0119034","article-title":"Activation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system","volume":"10","author":"Richard","year":"2015","journal-title":"PLoS One"},{"key":"B124","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0140-6736(23)01053-X","article-title":"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA","volume":"402","author":"Rosenstock","year":"2023","journal-title":"Lancet"},{"key":"B125","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s42255-020-0171-3","article-title":"Targeted pharmacological therapy restores beta-cell function for diabetes remission","volume":"2","author":"Sachs","year":"2020","journal-title":"Nat. Metab."},{"key":"B126","doi-asserted-by":"publisher","first-page":"8498","DOI":"10.1038\/s41467-024-52898-y","article-title":"Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy","volume":"15","author":"Sanchez-Garrido","year":"2024","journal-title":"Nat. Commun."},{"key":"B127","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/s0149-7634(00)00040-3","article-title":"Insulin receptors and insulin action in the brain: review and clinical implications","volume":"24","author":"Schulingkamp","year":"2000","journal-title":"Neurosci. Biobehav Rev."},{"key":"B128","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00125-014-3478-3","article-title":"GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice","volume":"58","author":"Schwenk","year":"2015","journal-title":"Diabetologia"},{"key":"B129","doi-asserted-by":"publisher","first-page":"m3684","DOI":"10.1136\/bmj.m3684","article-title":"Alzheimer's disease beyond amyloid: strategies for future therapeutic interventions","volume":"371","author":"Shi","year":"2020","journal-title":"BMJ"},{"key":"B130","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"e61965","DOI":"10.1371\/journal.pone.0061965","article-title":"Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward","volume":"8","author":"Shirazi","year":"2013","journal-title":"PLoS One"},{"key":"B132","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1007\/s12035-016-9951-x","article-title":"Mitochondrial metabolism power SIRT2-dependent deficient traffic causing alzheimer's-disease related pathology","volume":"54","author":"Silva","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1124\/mol.104.004465","article-title":"Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects","volume":"67","author":"Stirone","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3233\/JAD-170139","article-title":"Decreased methylation of the mitochondrial D-loop region in late-onset alzheimer's disease","volume":"59","author":"Stoccoro","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B135","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42003-020-01584-y","article-title":"Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP\/PS1 female mice","volume":"4","author":"Stojakovic","year":"2021","journal-title":"Commun. Biol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1385\/ENDO:29:2:209","article-title":"Mechanisms of neuroprotection by estrogen","volume":"29","author":"Suzuki","year":"2006","journal-title":"Endocrine"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.1081447","article-title":"The endocrine regulation of aging by insulin-like signals","volume":"299","author":"Tatar","year":"2003","journal-title":"Science"},{"key":"B138","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3233\/JAD-230911","article-title":"Comparative efficacy, tolerability, and acceptability of donanemab, lecanemab, aducanumab, melatonin, and aerobic exercise for a short time on cognitive function in mild cognitive impairment and mild Alzheimer's disease: a systematic review and network meta-analysis","volume":"98","author":"Terao","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"9446","DOI":"10.1038\/s41598-023-36602-6","article-title":"GLP-1 receptor agonist protects palmitate-induced insulin resistance in skeletal muscle cells by up-regulating sestrin2 to promote autophagy","volume":"13","author":"Tian","year":"2023","journal-title":"Sci. Rep."},{"key":"B140","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3969\/j.issn.1673-5374.2013.05.005","article-title":"Estrogen receptor beta treats Alzheimer's disease","volume":"8","author":"Tian","year":"2013","journal-title":"Neural Regen. Res."},{"key":"B141","doi-asserted-by":"publisher","first-page":"10211","DOI":"10.1038\/srep10211","article-title":"Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis","volume":"5","author":"Tiano","year":"2015","journal-title":"Sci. Rep."},{"key":"B142","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/379069a0","article-title":"A role for glucagon-like peptide-1 in the central regulation of feeding","volume":"379","author":"Turton","year":"1996","journal-title":"Nature"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s13760-020-01360-z","article-title":"Estrogen receptor beta (ESR2) gene polymorphism and susceptibility to dementia","volume":"121","author":"Ulhaq","year":"2021","journal-title":"Acta Neurol. Belg"},{"key":"B144","doi-asserted-by":"publisher","first-page":"104904","DOI":"10.1016\/j.neuint.2020.104904","article-title":"Estrogen receptors-beta and serotonin mediate the antidepressant-like effect of an aqueous extract of pomegranate in ovariectomized rats","volume":"142","author":"Valdes-Sustaita","year":"2021","journal-title":"Neurochem. Int."},{"key":"B145","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B146","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.maturitas.2016.05.014","article-title":"The functions of estrogen receptor beta in the female brain: a systematic review","volume":"93","author":"Vargas","year":"2016","journal-title":"Maturitas"},{"key":"B147","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.yhbeh.2012.03.018","article-title":"Sex and hormonal influences on seizures and epilepsy","volume":"63","author":"Veliskova","year":"2013","journal-title":"Horm. Behav."},{"key":"B148","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuropharm.2016.07.039","article-title":"GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight","volume":"110","author":"Vogel","year":"2016","journal-title":"Neuropharmacology"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e033654","DOI":"10.1161\/JAHA.123.033654","article-title":"Genetics and pathophysiological mechanisms of lipoprotein(a)-associated cardiovascular risk","volume":"13","author":"Volgman","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"B150","doi-asserted-by":"publisher","first-page":"n1682","DOI":"10.1136\/bmj.n1682","article-title":"Aducanumab for Alzheimer's disease?","volume":"374","author":"Walsh","year":"2021","journal-title":"BMJ"},{"key":"B151","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1471-4159.2005.03053.x","article-title":"Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease","volume":"93","author":"Wang","year":"2005","journal-title":"J. Neurochem."},{"key":"B152","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mp.2014.23","article-title":"Estrogen receptor \u03b2 and Liver X receptor \u03b2: biology and therapeutic potential in CNS diseases","volume":"20","author":"Warner","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"B153","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/JAD-200286","article-title":"Mitochondrial DNA manipulations affect tau oligomerization","volume":"77","author":"Weidling","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B154","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.brainresrev.2007.05.013","article-title":"Estrogen receptor beta in the brain: from form to function","volume":"57","author":"Weiser","year":"2008","journal-title":"Brain Res. Rev."},{"key":"B155","doi-asserted-by":"publisher","first-page":"118645","DOI":"10.1016\/j.lfs.2020.118645","article-title":"GLP-1 mimetics and cognition","volume":"264","author":"Yaribeygi","year":"2021","journal-title":"Life Sci."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J."},{"key":"B157","doi-asserted-by":"publisher","first-page":"10873","DOI":"10.1074\/jbc.M608856200","article-title":"Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation","volume":"282","author":"Zhang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B158","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/nn.4025","article-title":"Central role for PICALM in amyloid-beta blood-brain barrier transcytosis and clearance","volume":"18","author":"Zhao","year":"2015","journal-title":"Nat. Neurosci."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2025.1622186\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:10:51Z","timestamp":1750911051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2025.1622186\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":158,"alternative-id":["10.3389\/fmolb.2025.1622186"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2025.1622186","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]},"article-number":"1622186"}}